Condition
Hereditary Retinal Dystrophies
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Octa
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Terminated1
Clinical Trials (1)
Research Network
Common Treatments
- Octa1
- Visual Acuity Etdrs1
Active Sponsors
- Fondation Ophtalmologique Adolphe de Rothschild1
Top Investigators
Fondation Ophtalmologique A. de Rothschild